.jpg)
.png)
NLA News
After years of thoughtful planning and development, the National Lipid Association (NLA) recently released its first edition of the Annual Summary of Clinical Lipidology. The first issue, which was published as a supplement to the November/December issue of the Journal of Clinical... more
The National Lipid Association (NLA) endorses the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk, published by the American College of Cardiology on April 1 in the Journal... more
The results of the HPS2-THRIVE study were released in the New England Journal of Medicine on July 17, 2014. Also, appearing in the same edition was a special correspondence from the AIM HIGH investigators concerning further analysis of adverse events, and an editorial addressing both of... more
Amgen announced today that the FOURIER trial met its primary and secondary endpoints in evaluating whether evolocumab reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease (ASCVD) without new safety issues. Amgen also announced that the... more
The 2013 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw a significant increase — from 2.741 (2012) to 3.587. The Journal is now ranked 53rd out of 254 journals in its category (pharmacology and pharmacy). “This a very large change in... more
Joyce Ross, CRNP, MSN, Assumes Role of President during the 2016 NLA Scientific Sessions in New Orleans Jacksonville, Florida (May 26, 2016) — Joyce Ross, MSN, ANP, CLS, CRNP, FPCNA, FNLA, assumed her role as president of the National Lipid Association (NLA) during the business meeting... more
Dr. Joseph Witztum Receives W. Virgil Brown Distinguished Achievement Award, Drs. Jonathan Cohen, Edward Fisher, and Helen Hobbs, Receive NLA Honorary Lifetime Award Joseph L. Witztum, MD, received the first ever W. Virgil Brown Distinguished Achievement Award during the annual Honors and... more
James A. Underberg, MD, Elected by NLA Members during the 2016 NLA Scientific Sessions in New Orleans The National Lipid Association (NLA) announces the appointment of James A. Underberg, MD, MS, FACPM, FACP, FASPC, FNLA, as president-elect. NLA members voted on the slate of new nominees during... more
The 2015 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw yet another significant increase — from 3.904 (2014) to 4.906 (2015). The Journal is now ranked 23rd out of 253 journals in its category (pharmacology and pharmacy... more
The National Lipid Association (NLA) welcomes the results of the REVEAL trial which demonstrated that reductions in cholesterol levels with anacetrapib were associated with a reduction in cardiovascular events. Specifically, cholesterol drug anacetrapib produced reductions in low density... more